Measurement of Two Markers in urine samples enables colorectal cancer risk diagnosis with sensitivity: 94.3%, specificity: 63.4%, AUC=0.870.
Gene copy number profile of extracellular vesicles in body fluid to determine the sensitivity of ovarian cancer to the anticancer drug PARP inhibitors.
Novel therapeutic approach targeting the release mechanism of senescence-associated secretory phenotype (SASP) factors from senescent cells
Prediction of the efficacy of cancer immunotherapy using the tumor-targeting activity of T cells in peripheral blood.
-Two independent antisense oligonucleotides (ASOs) targeting GREB1 and Arl4c gene-
Original method and hepatocyte reproduced hepatobiliary function
One Step N-terminal Ligation with Functional Compounds
Screening test for early stage gastric cancer, esophageal cancer and colorectal cancer patients by measuring urine miRNAs specific to each cancer.
CHRNB2, a novel target for gastric cancer, potentially other tumors
One step 2-nitroimidazole active site capping of commercialized compound.